格隆汇3月13日丨复旦张江(01349.HK)发布公告，集团研发的盐酸氨酮戊酸颗粒剂(“该药物”)用于非肌层浸润性膀胱癌手术切除辅助的验证性临床研究(“该研究”)于近日成功完成首例受试者入组。膀胱癌是一种复发率较高的恶性肿瘤。根据肿瘤是否浸润到膀胱肌层可以分为非肌层浸润性膀胱癌(“NMIBC”)和肌层浸润性膀胱癌(MIBC)。据公开资料显示， NMIBC 约占膀胱癌的75%。经尿道膀胱癌切除术(“...
Source Link格隆汇3月13日丨复旦张江(01349.HK)发布公告，集团研发的盐酸氨酮戊酸颗粒剂(“该药物”)用于非肌层浸润性膀胱癌手术切除辅助的验证性临床研究(“该研究”)于近日成功完成首例受试者入组。膀胱癌是一种复发率较高的恶性肿瘤。根据肿瘤是否浸润到膀胱肌层可以分为非肌层浸润性膀胱癌(“NMIBC”)和肌层浸润性膀胱癌(MIBC)。据公开资料显示， NMIBC 约占膀胱癌的75%。经尿道膀胱癌切除术(“...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.